U.S. markets closed

  • S&P 500

    3,811.15
    -18.19 (-0.48%)
     

  • Dow 30

    30,932.37
    -469.63 (-1.50%)
     

  • Nasdaq

    13,192.35
    +72.95 (+0.56%)
     

  • Russell 2000

    2,201.05
    +0.88 (+0.04%)
     

  • Crude Oil

    61.66
    +0.16 (+0.26%)
     

  • Gold

    1,733.00
    +4.20 (+0.24%)
     

  • Silver

    26.70
    +0.26 (+0.98%)
     

  • EUR/USD

    1.2079
    -0.0107 (-0.88%)
     

  • 10-Yr Bond

    1.4600
    -0.0580 (-3.82%)
     

  • GBP/USD

    1.3941
    -0.0072 (-0.51%)
     

  • USD/JPY

    106.5110
    +0.2810 (+0.26%)
     

  • BTC-USD

    45,037.30
    -1,998.06 (-4.25%)
     

  • CMC Crypto 200

    912.88
    -20.25 (-2.17%)
     

  • FTSE 100

    6,483.43
    -168.53 (-2.53%)
     

  • Nikkei 225

    28,966.01
    -1,202.29 (-3.99%)
     

Novocure Finds Support

Novocure (NVCR) is making a nice first test of its 50-day line, although Thursday’s gains came in lower volume. Oncology firm known for its therapy called TTFields, which uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division.